$0.293200
0.0312.77%
At close: -
$0.275100
-0.02-6.17%
After Hours: 7:57 PM EDT
Comments
Loading...
Syros Pharmaceuticals (SYRS) Forecast
NewsEarningsSyros Pharmaceuticals (SYRS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestSyros Pharmaceuticals (NASDAQ:SYRS) Stock Quotes, Forecast and News Summary
Syros Pharmaceuticals Stock (NASDAQ: SYRS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Syros Pharmaceuticals (SYRS) stock?
You can purchase shares of Syros Pharmaceuticals (NASDAQ:SYRS) through any online brokerage.
Who are Syros Pharmaceuticals (SYRS) competitors?
Other companies in Syros Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO), Addex Therapeutics (NASDAQ:ADXN) and Coeptis Therapeutics (NASDAQ:COEP).
What is the forecast, or price target, for Syros Pharmaceuticals (SYRS) stock?
Syros Pharmaceuticals has a consensus price target of $7.25.
What is the current price for Syros Pharmaceuticals (SYRS)?
The stock price for Syros Pharmaceuticals (NASDAQ: SYRS) is $0.2751 last updated November 22, 2024 at 7:57 PM EST.
Does Syros Pharmaceuticals (SYRS) pay a dividend?
There are no upcoming dividends for Syros Pharmaceuticals.
When is Syros Pharmaceuticals (NASDAQ:SYRS) reporting earnings?
Syros Pharmaceuticals’s Q3 earnings are confirmed for Thursday, October 31, 2024.
Is Syros Pharmaceuticals (SYRS) going to split?
There is no upcoming split for Syros Pharmaceuticals.
What sector and industry does Syros Pharmaceuticals (SYRS) operate in?
Syros Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.